Seeing Is Believing
Healthcare - Sector
RGNX is currently covered by 5 analysts with an average price target of $37.18. This is a potential upside of $23.67 (175.2%) from yesterday's end of day stock price of $13.51.
Regenxbio's activity chart (see below) currently has 140 price targets and 138 ratings on display. The stock rating distribution of RGNX is 87.5% BUY and 12.5% HOLD.
Analysts average stock forecasts to be materialized ratio is 26% with an average time for these price targets to be met of 76.16 days.
Highest price target for RGNX is $52, Lowest price target is $12, average price target is $28.2.
Most recent stock forecast was given by DANIIL GATAULIN from CHARDAN CAPITAL on 20-Nov-2025. First documented stock forecast 12-Oct-2015.
Currently out of the existing stock ratings of RGNX, 14 are a BUY (87.5%), 2 are a HOLD (12.5%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$52
$38.61 (288.35%)
28 days ago
(20-Nov-2025)
0/7 (0%)
$41.13 (378.38%)
Buy
$19
$5.61 (41.90%)
$25
1 months 11 days ago
(07-Nov-2025)
4/15 (26.67%)
$7.79 (69.49%)
50
Buy
$34
$20.61 (153.92%)
$34
3 months 10 days ago
(08-Sep-2025)
0/11 (0%)
$24.52 (258.65%)
Hold
$12
$-1.39 (-10.38%)
$14
8 months 1 days ago
(17-Apr-2025)
1/3 (33.33%)
$6.06 (102.02%)
174
Buy
$24
$10.61 (79.24%)
$22
9 months 4 days ago
(14-Mar-2025)
0/2 (0%)
$17.28 (257.14%)
What is RGNX (Regenxbio) average time for price targets to be met?
Which analyst has the current highest performing score on RGNX (Regenxbio) with a proven track record?
Which analyst has the most public recommendations on RGNX (Regenxbio)?
Which analyst is the currently most bullish on RGNX (Regenxbio)?
Which analyst is the currently most reserved on RGNX (Regenxbio)?